During the past decade, Clintheory Healthcare conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clintheory Healthcare" are "Ulcerative Colitis" (3 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "Clintheory Healthcare" in a lesser frequency.

Most popular intervention types in "Clintheory Healthcare" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Mirikizumab" (4 trials), "Placebo" (2 trials), "Mirikizumab IV" (1 trials), "Mirikizumab SC" (1 trials) and "Placebo SC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clintheory Healthcare" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Clintheory Healthcare". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Clintheory Healthcare, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clintheory Healthcare, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".